Myriad Genetics Inc. Equity-NMS: MYGN

Healthcare

Diagnostics & Research

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Error in Fetching Data, Please retry later.
Previous close :$8.8
Open :$8.46
Today's high :$8.74
Today's low :$8.11
52W low :$8.11
52W high :$29.3
EPS(TTM): :-1.41
Shares O/S :91.31 M
Market cap :767.91 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Myriad Genetics Inc. $8.41 -0.01% - 767.91M

Frequently Asked Questions

What is the share price of Myriad Genetics Inc. today?

Myriad Genetics Inc. (MYGN) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Myriad Genetics Inc.

Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health, and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test, which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, Foresight, Prequel, Precis Tumor, Precise Liquid, SneakPeek and GeneSight, among others.